Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 95,400 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Jun 24, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Jun 7, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 191,082 | n/a |
| Jun 15, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 74,561 | n/a |
| Aug 15, 2022 | Allogene Therapeutics, Inc. (ALLO) | Sale | 10,000 | $165.0K |
| Aug 15, 2022 | Allogene Therapeutics, Inc. (ALLO) | Sale | 10,000 | $165.0K |
| Jun 23, 2022 | Allogene Therapeutics, Inc. (ALLO) | Sale | 10,000 | $117.6K |
| Jun 17, 2022 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 22,089 | n/a |
| Sep 9, 2021 | Allogene Therapeutics, Inc. (ALLO) | Sale | 5,000 | $127.7K |
| Aug 23, 2021 | Allogene Therapeutics, Inc. (ALLO) | Sale | 5,000 | $118.5K |